Allurion Technologies Inc. (ALUR)
NYSE: ALUR · Real-Time Price · USD
1.400
-0.140 (-9.09%)
At close: Jan 22, 2026, 4:00 PM EST
1.400
0.00 (0.00%)
After-hours: Jan 22, 2026, 7:00 PM EST
Allurion Technologies Employees
As of December 31, 2024, Allurion Technologies had 137 total employees, including 134 full-time and 3 part-time employees. The number of employees decreased by 115 or -45.63% compared to the previous year.
Employees
137
Change (1Y)
-115
Growth (1Y)
-45.63%
Revenue / Employee
$125,606
Profits / Employee
-$235,971
Market Cap
17.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 137 | -115 | -45.63% | 134 | 3 |
| Dec 31, 2023 | 252 | -4 | -1.56% | 249 | 3 |
| Sep 30, 2023 | 268 | 12 | 4.69% | 268 | 0 |
| Jun 30, 2023 | 268 | - | - | 266 | 2 |
| Mar 31, 2023 | 256 | - | - | 252 | 4 |
| Dec 31, 2022 | 256 | - | - | 256 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Nortech Systems | 744 |
| Trinity Biotech | 401 |
| Vicarious Surgical | 123 |
| Vivos Therapeutics | 109 |
| IRIDEX | 93 |
| Adagio Medical Holdings | 80 |
| Lifeward | 80 |
| Beyond Air | 61 |
ALUR News
- 10 days ago - Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results - Business Wire
- 2 months ago - Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence - Business Wire
- 2 months ago - New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone - Business Wire
- 2 months ago - Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss - Business Wire
- 2 months ago - Allurion Technologies Inc. (ALUR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire
- 2 months ago - Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being Debt-Free, and Announces a $5 Million Private Placement Financing - Business Wire
- 2 months ago - Allurion to Report Third Quarter 2025 Financial Results on November 12, 2025 - Business Wire